# IMPLEMENTATION_REPORT — Device Intelligence production-readiness evidence v1

> **NON-GOVERNED RESEARCH CANDIDATES**
> **NOT CONSUMED BY RUNTIME**
> **PHYSICIAN REVIEW REQUIRED BEFORE ADOPTION**

## Goal

Move the Device and Procedure Intelligence Platform as close as safely possible to a credible
production-quality unlisted beta by producing a traceable evidence packet, deterministic review
tooling, a launch assessment, and a future implementation plan—without letting research become
governed clinical truth.

## Scope and constraints

- Frozen repository commit:
  `2f26cb7632fe4e8f6835a8528458b672e8f360c2`.
- Working branch:
  `codex/device-intelligence-production-readiness-evidence-v1`.
- One orientation fetch was performed; no pull, merge, rebase, reset, cherry-pick, force-push, or PR
  branch switch occurred.
- Only additive files under `docs/ip-device-intelligence/production-readiness/**` and
  `scripts/ip-device-intelligence/production-readiness/**` changed.
- Governed data, application/runtime code, shared package/messages, feature flags, release pointers,
  navigation, sitemap, and noindex behavior were not modified.
- No database, Supabase, upload, or production operation occurred.
- PR #91/#92 were inspected read-only and were not modified.

## Plan completed

1. Verified the clean frozen worktree, branch, SHA, worktree list, origin/main, and active PR
   metadata.
2. Audited the frozen D1 specification, generated product/role/procedure/slot/option/source/rule
   graph, runtime boundaries, and read-only active PR diffs.
3. Ran two parallel official-source research streams: launch-critical exemplars and owner-supplied
   Tier 0.
4. Implemented a versioned non-governed manifest schema, semantic validator, deterministic report
   generator, CLI wrappers, fixture, and focused tests.
5. Authored an 86-record manifest covering 47 evidence targets, including all 35 exact Tier 0
   configurations.
6. Generated source, conflict, decision, blocker, and owner reports; authored the executive, scope,
   method, hardening, and post-merge packets.
7. Performed an independent adversarial review, hardened eleven tooling/reporting weaknesses, and added literal
   35-identity regression coverage.
8. Ran focused verification and byte-identical generation. No full repository suite was needed
   because no code outside the isolated additive tooling scope changed.
9. Committed tooling separately; the evidence/document commit containing this report follows.

## Changes made

### Tooling — three commits

- `8e10376f9eec850552fe41a4e6a9133e8f018861`
- `803957ead80eb287c5d77e140ea80da2b01e47c7`
- `54993119a700037c46a66f271babaa7ca2a50572`

- `scripts/ip-device-intelligence/production-readiness/README.md`
- `scripts/ip-device-intelligence/production-readiness/evidence-manifest.schema.v1.json`
- `scripts/ip-device-intelligence/production-readiness/evidence-manifest.ts`
- `scripts/ip-device-intelligence/production-readiness/validate-evidence-manifest.ts`
- `scripts/ip-device-intelligence/production-readiness/generate-reports.ts`
- `scripts/ip-device-intelligence/production-readiness/fixtures/minimal-valid-manifest.json`
- `scripts/ip-device-intelligence/production-readiness/__tests__/production-readiness-tooling.test.ts`

### Evidence and assessment packet — commit containing this report

- `docs/ip-device-intelligence/production-readiness/README.md`
- `docs/ip-device-intelligence/production-readiness/executive-launch-assessment.md`
- `docs/ip-device-intelligence/production-readiness/launch-critical-scope.md`
- `docs/ip-device-intelligence/production-readiness/evidence-method.md`
- `docs/ip-device-intelligence/production-readiness/device-use-evidence-manifest.json`
- `docs/ip-device-intelligence/production-readiness/source-coverage-report.md`
- `docs/ip-device-intelligence/production-readiness/evidence-conflicts.md`
- `docs/ip-device-intelligence/production-readiness/physician-adjudication-queue.md`
- `docs/ip-device-intelligence/production-readiness/launch-blocker-matrix.md`
- `docs/ip-device-intelligence/production-readiness/production-hardening-backlog.md`
- `docs/ip-device-intelligence/production-readiness/owner-supplied-missing-products.md`
- `docs/ip-device-intelligence/production-readiness/post-merge-implementation-plan.md`
- `docs/ip-device-intelligence/production-readiness/implementation-report.md`

No other file changed.

## Evidence summary

The packet's three production blockers are:

1. 33 public AERO/AERO DV sterile fields conflict with current manufacturer IFUs at the
   family-claim level; exact row correction additionally requires an IFU/order-code applicability
   crosswalk.
2. The required EBUS video slot has no evidenced public BF-UC190F path.
3. No named clinical owner/signoff is recorded for the three D1 exemplars.

The manifest contains 43 supported records, 32 partially supported Portex component-group
inferences, 4 records in two confirmed conflict pairs, and 7 explicit primary-source gaps. It does
not contain an approved, rejected, or adopted record.

## Tests and verification

Completed gates:

- focused Jest: **27/27 passed**;
- TypeScript `npx tsc --noEmit`: passed;
- ESLint on additive tooling with zero warnings: passed;
- Prettier on changed files: passed;
- production manifest validator: **86 records valid**;
- literal production-manifest test: exactly **35 Tier 0 identities**;
- deterministic generator: five reports written twice to independent directories and
  byte-identical under `diff -ru`;
- programmatic generator input validation, code-point sort, claim-tier closure, conflict reciprocity,
  prohibited semantic assertion, exact identity, and safe-proposal regression tests: passed;
- `git diff --check` and staged whitespace gate: passed;
- pre-commit lint-staged gate for tooling: passed.

The CLI emits a Node `DEP0205` deprecation warning from the repository's current tsx/module-loader
path. It does not alter output bytes or validation results.

## Required final handoff

1. **Worktree:** `/Users/russellmiller/Projects/Interventional-Pulm-Education-Worktrees/codex-e`.
2. **Branch:** `codex/device-intelligence-production-readiness-evidence-v1`.
3. **Frozen starting SHA:** `2f26cb7632fe4e8f6835a8528458b672e8f360c2`.
4. **Final SHA:** the evidence-packet commit containing this report; its exact Git object ID is
   reported in the external handoff because a commit cannot contain its own hash.
5. **PR #91 observed:** OPEN draft; base `main`; head
   `claude/device-intelligence-governed-data-corrections`;
   `eaad0ff9db17423a7c13472d15a85a8e29729e76`; title “fix(device-intelligence): apply
   owner-reviewed governed-data corrections”.
6. **PR #92 observed:** OPEN draft; base PR #91 branch; head
   `claude/preference-card-definition-set-retention-f09`;
   `e1b45135380e4c4c142a04d862ce87f012a26c20`; title “feat(preference-cards): retain
   definition sets and complete APC F-09”.
7. **Exact files changed:** the 20 files listed under “Changes made”; all are in the two authorized
   additive directories.
8. **Commits created:** tooling
   `8e10376f9eec850552fe41a4e6a9133e8f018861`; format-stable report follow-up
   `803957ead80eb287c5d77e140ea80da2b01e47c7`; family-risk reporting follow-up
   `54993119a700037c46a66f271babaa7ca2a50572`; one evidence/document commit containing this report.
   Exact final commit/push IDs are reported after the commit in the external handoff.
9. **Agent roles/workstreams:** root orchestrator/reviewer; launch-critical internet researcher;
   Tier 0 internet researcher; implementor/tooling agent; independent adversarial reviewer; final
   packet reviewer.
10. **Tier 0 reviewed:** **35 exact configurations**—3 Medtronic, 14 BLUperc, 18 BLUgriggs.
11. **Tier 1 reviewed:** **45 required/conditional slot memberships / 39 unique roles**.
12. **Tier 2 reviewed:** **217 memberships / 202 distinct products / 48
    procedure-role-manufacturer-family surfaces**.
13. **Tier 3 reviewed:** **31 distinct frozen compatibility rules** plus **14 prioritized external
    compatibility/safety claim surfaces** in the broader read-only inventory. Exactly 9 Tier 3
    targets / 9 Tier 3 records are represented in the manifest and generated reports.
14. **Sources reviewed:** 33 frozen exemplar source records plus **86 external source URLs/documents**
    across both research streams (38 launch-critical; 48 Tier 0 when all 32 exact Portex GUDID pages
    are counted). This is the broader read-only research ledger, not a claim that all source reviews
    became manifest candidates; the manifest itself has 24 distinct source URLs / 25 source
    documents.
15. **External source-quality distribution:** 22 manufacturer IFU/manual/official-labeling or
    compatibility documents; 45 regulatory sources; 16 manufacturer web/brochure sources; 3
    peer-reviewed/society context sources; 7 explicit unresolved search records in the manifest.
16. **Candidate facts identified:** 86 manifest records / 47 coverage targets: 43 supported, 32
    partially supported, 4 conflicting, 7 primary-source gaps.
17. **Ready for physician adjudication:** 78 individual records are
    `READY_FOR_PHYSICIAN_REVIEW`; every one of the 35 Tier 0 configurations has at least one
    review-ready exact fact/decision record. This is not governed-ingestion readiness.
18. **Conflicting claims:** two confirmed sterile-status claim keys / four reciprocal records:
    AERO and AERO DV.
19. **Unsupported current claims:** EBUS and therapeutic scope/video choices, Pentax needle
    co-selection against the public Olympus cohort, ReSolve-to-Oasis direct fit, exact laser/ETT,
    ERBE probe, and Micro-Tech TT relationships, and broad unresolved chest IPC targets. The
    generated reports cover only named manifest candidates; the laser/ETT, ERBE, Micro-Tech, and
    some other broad gaps remain read-only research inventory/backlog context.
20. **Model-versus-family risks:** family brochures/marketing cannot qualify exact model
    compatibility, indication, sterile/reuse, embedded kit child identity, or current U.S.
    jurisdiction.
21. **Compatibility gaps:** exact EBUS tower, therapeutic video systems, Cook hub enforcement,
    chest adapter/IPC targets, exact balloon accessory choices, APC probe chain, laser/ETT, and
    Medtronic powered-system chain.
22. **Stale sources:** at a 365-day cue, 44 manifest records / 15 unique source URLs are stale; 39
    records / 7 URLs are undated. The undated total includes the 32 bounded Portex web-page
    crosswalk records. Staleness triggers review and is not a falsity determination.
23. **Missing primary sources:** 7 explicit manifest search records, plus the broader documented
    exact gaps for current U.S. Portex package labeling, forceps/reprocessing, ERBE APC probe,
    Micro-Tech TT, laser/ETT, and local system configurations.
24. **Owner-supplied findings:** `1899200`, `1884033HRE`, and `1884035HRE` are wholly absent
    exact candidates; all 32 Portex codes exist only as raw source-ingest rows and remain incomplete.
    No Tier 0 target passes the conservative governed-proposal gate.
25. **Kit/BOM implications:** 12 Portex profiles summarize tube/no-tube, Suctionaid, forceps,
    medication, and size distinctions. Each is now traceable to the manufacturer component-group
    page plus exact GUDID identity and explicitly classified as a partially supported researcher
    inference—not an exact-suffix package BOM. Nested-kit, child identity, dependency, suppression,
    and lot-level safety still require evidence and decisions. The Medtronic powered system also
    needs componentized modeling.
26. **Physician queue:** 86 open records—78 ready for review, 1 pending, 7 not ready. No AI-authored
    recommendation is recorded as an owner decision.
27. **Launch blockers:** three unique BLOCKER classes (seven manifest rows because each conflict side
    remains traceable); six manifest HIGH rows plus broader source/content/runtime high findings;
    mobile/state/analytics/print/performance work is MEDIUM; translation/visual polish is LOW.
28. **Resolved in active PRs:** PR #91 F-04/F-05/F-06/F-10 and PR #92 F-09,
    definition-set-retention, and launch-harness work are **RESOLVED IN ACTIVE PR — VERIFY AFTER
    MERGE**. Neither branch is frozen truth.
29. **Safe tooling:** versioned JSON Schema, semantic validator, deterministic generator, five
    reports, direct CLIs, fixture, exact production-manifest regression, and adversarial tests.
30. **Production-hardening backlog:** 20 prioritized records covering data conflicts, exact system
    edges, source UX, stale/missing states, mobile overflow, loading/error/empty states, analytics,
    print, performance, accessibility, translation, and polish.
31. **Post-merge plan:** A—Rocket after approval; B—AERO exact IFU applicability plus
    EBUS/Medtronic/Portex/chest/exact-source closure; C—powered-system, nested-kit, and lot-aware
    models; D—compatibility/source/state UX; E—keep recalled ViziShot hidden and do not ingest
    unqualified assertions.
32. **Tests/gates:** all gates listed in “Tests and verification” passed; full suite intentionally
    omitted because no shared/runtime code changed.
33. **Determinism:** five generated reports were byte-identical across two independent directories.
    Dates are explicit inputs; no intentionally nondeterministic artifact remains.
34. **Prohibited file confirmation:** no governed/runtime/data/release/package/messages file changed.
35. **Database confirmation:** no database/Supabase operation occurred; local analytics failed before
    client creation due absent configuration.
36. **Feature flag confirmation:** production was not enabled and flag code was not modified.
37. **Navigation confirmation:** navigation, sitemap, and noindex behavior were not modified.
38. **PR confirmation:** PR #91/#92 branches, metadata, titles, bodies, bases, and files were not
    modified.
39. **Post-PR sequence:** verify PRs; obtain clinical ownership; establish AERO exact applicability
    and correct only qualified rows; implement one exact EBUS tower; bound high-risk pairs; add
    source/state UX; run merged and unique launch checks.
40. **AABIP path:** keep unlisted/noindexed/flag-gated; show only exact approved systems; fail closed
    on unsupported identities/pairs; retain source/revision/limitations in screenshots and print.
41. **Clean worktree:** required and verified after the evidence commit; the external handoff reports
    the final `git status --short` result.
42. **Remote branch:** push target is only
    `origin/codex/device-intelligence-production-readiness-evidence-v1`; the external handoff
    confirms the push that necessarily follows the commit containing this report.

## Open questions

All clinical/governance questions are in the generated physician queue. Highest priority: accountable
clinical owners, AERO source adjudication, exact local EBUS tower, and exact locally permitted system
pairs.

## Next recommended step

Physician/data-owner review of the generated queue and blocker matrix, followed by the bounded
post-PR sequence. Do not begin governed implementation from this branch.

## FINAL VERDICT

**READY FOR PHYSICIAN EVIDENCE REVIEW**

This verdict does not mean ready for production.

This material is educational governance support, not clinical advice. Exact device use requires
current jurisdiction-specific labeling, trained clinicians, local biomedical validation, and
institutional policy.
